Skip to main content
. 2022 Apr 13;11(8):2167. doi: 10.3390/jcm11082167

Figure 2.

Figure 2

The different strategies proposed for the prevention and treatment of contrast-associated acute kidney injury. The green therapies have been shown to reduce contrast-associated acute kidney injury, the yellow therapies are controversial, while the red treatment is not effective. NSAIDs: non-steroidal anti-inflammatory drugs; RAS: renin–angiotensin system; RIC: remote ischemic conditioning; CM: contrast media.